insights_auto
Why is 0QF up 2,51%?
Dive Deeperchevron_right
0QF:ETR
Moderna Inc
€175,42
arrow_upward
+2,51%(+4,30) 1D
29 ກ.ຍ., 17 ໂມງ 35 ນາທີ 33 ວິນາທີ GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
€173,12
High
€184,20
Low
€171,00
Mkt. cap
81,23 ຕື້
Avg. vol.
43,79 ພັນ
Volume
25,81 ພັນ
52-wk high
€184,20
52-wk low
€19,37
No. of employees
5 ພັນ
Open
€173,12
High
€184,20
Low
€171,00
Mkt. cap
81,23 ຕື້
Avg. vol.
43,79 ພັນ
Volume
25,81 ພັນ
52-wk high
€184,20
52-wk low
€19,37
No. of employees
5 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
·
3 ຊົ່ວໂມງກ່ອນ
Moderna stock after-hours at EUR 176.87: plus 1.89 percent versus Lang & Schwarz prior close
Investing.com
·
8 ຊົ່ວໂມງກ່ອນ
Moderna stock hits 52-week high at 202.69 USD
AD HOC NEWS
·
12 ຊົ່ວໂມງກ່ອນ
Moderna stock trades at EUR 172.26 ahead of melanoma data
The Globe and Mail
·
1 ມື້ກ່ອນ
Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc
CEOStéphane Bancel
Employees4,7 ພັນ
Foundedກ.ຍ. 2010
Headquarters-
SectorBiotechnology
Websitemodernatx.com